MARKET

GUTS

GUTS

Fractyl Health
NASDAQ
0.9656
+0.0173
+1.82%
Opening 10:42 05/14 EDT
OPEN
1.020
PREV CLOSE
0.9483
HIGH
1.030
LOW
0.9100
VOLUME
2.66M
TURNOVER
--
52 WEEK HIGH
3.030
52 WEEK LOW
0.3772
MARKET CAP
153.19M
P/E (TTM)
-0.5194
1D
5D
1M
3M
1Y
5Y
1D
Fractyl Health’s Pivotal Year: Inside the Earnings Call
TipRanks · 14h ago
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga · 21h ago
Analysts Have Conflicting Sentiments on These Healthcare Companies: Intellia Therapeutics (NTLA), TriSalus Life Sciences (TLSI) and Fractyl Health, Inc. (GUTS)
TipRanks · 1d ago
Analysts Offer Insights on Healthcare Companies: Fractyl Health, Inc. (GUTS), UnitedHealth (UNH) and TELA Bio (TELA)
TipRanks · 1d ago
Fractyl targets early Q4 2026 REMAIN-1 pivotal readout amid plans for late Q4 2026 de novo submission
Seeking Alpha · 1d ago
Fractyl Health reports Q1 EPS 6c, consensus (16c)
TipRanks · 1d ago
Fractyl Health Q1 2026 Earnings Call: Complete Transcript
Benzinga · 1d ago
BRIEF-Fractyl Health Reports First Quarter 2026 Financial Results
Reuters · 1d ago
More
About GUTS
Fractyl Health, Inc. is a metabolic therapeutics company. The Company is focused on developing new approaches to the treatment of metabolic diseases, including obesity and type 2 diabetes (T2D). The Company’s lead product candidate, Revita, is designed to remodel the duodenal lining via hydrothermal ablation (i.e. duodenal mucosal resurfacing) to reverse damage to intestinal nutrient sensing and signaling mechanisms caused by chronic high-fat and high-sugar diets that are a root cause of metabolic disease. The Revita clinical program is focused on patients living with obesity who want to maintain their weight loss after GLP-1 drug discontinuation. The Company’s Rejuva platform focuses on developing adeno-associated virus (AAV)-based, locally delivered gene therapies for the treatment of obesity and T2D. The Rejuva platform leverages advanced delivery systems and proprietary screening methods to identify and develop metabolically active gene therapy candidates targeting the pancreas.

Webull offers Fractyl Health Inc stock information, including NASDAQ: GUTS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, GUTS stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading GUTS stock methods without spending real money on the virtual paper trading platform.